◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksM › MCK

McKesson Corporation (MCK) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Distributors · DATA UPDATED 2026-08-23

McKesson Corporation (MCK) operates in the Health Care Distributors industry and is headquartered in Irving, United States with about 41,600 employees. Its market capitalization is roughly $102 billion. In the fiscal year ended 2026-03-31, MCK reported $403.4B in revenue and $4.8B in net income.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.

Interactive charts & full statements → Open the MCK valuation workbench →

MCK Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Total Revenue$411.0B$403.4B$359.1B$309.0B$276.7B$264.0B$238.2B$231.1B$214.3B$208.4B$198.5B$190.9B$179.0B$137.6B$122.5B$122.7B$112.1B$108.7B$106.6B$101.7B$93.0B
Gross Profit$15.0B$14.6B$12.5B$12.2B$11.9B$12.6B$11.6B$11.4B$10.8B$10.4B$10.7B$10.9B$10.9B$8.0B$6.8B$6.4B$6.0B$5.7B$5.4B$5.0B$4.3B
Gross Margin %3.6%3.6%3.5%4.0%4.3%4.8%4.9%4.9%5.0%5.0%5.4%5.7%6.1%5.8%5.5%5.2%5.3%5.2%5.1%4.9%4.7%
Operating Income (EBIT)$6.7B$6.5B$4.4B$3.9B$4.5B$2.7B$3.5B$3.0B$3.1B$2.9B$3.4B$3.9B$3.5B$2.6B$2.4B$2.4B$2.1B$2.0B$1.7B$1.5B$1.3B
Operating Margin %1.6%1.6%1.2%1.3%1.6%1.0%1.5%1.3%1.4%1.4%1.7%2.0%2.0%1.9%2.0%1.9%1.9%1.8%1.6%1.5%1.4%
Net Income$4.6B$4.8B$3.3B$3.0B$3.6B$1.1B($4.5B)$900M$34M$67M$5.2B$2.3B$1.5B$1.3B$1.3B$1.4B$1.1B$1.3B$823M$990M$963M
Net Margin %1.1%1.2%0.9%1.0%1.3%0.4%-1.9%0.4%0.0%0.0%2.6%1.2%0.8%0.9%1.1%1.1%1.0%1.2%0.8%1.0%1.0%
EBITDA$7.1B$7.2B$5.3B$4.7B$5.7B$3.1B($3.6B)$2.3B$1.8B$1.5B$8.1B$4.5B$4.0B$3.1B$2.7B$2.7B$2.3B$2.5B$1.6B$2.0B$1.7B
Earnings Per Share (EPS)$37.37$38.37$25.72$22.39$25.04$7.23$-28.26$4.95$0.17$0.32$23.24$9.69$6.28$5.42$5.60$5.59$4.30$4.63$2.95$3.32$3.16
Shares Outstanding (M)119M124M128M134M142M154M161M182M197M209M223M233M235M233M239M251M263M273M279M298M305M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$105.4B$96.3B$106.2B$103.2B$97.8B$90.8B$95.3B$93.7B
Gross Profit$3.7B$4.0B$3.7B$3.5B$3.3B$2.9B$3.2B$3.1B
Gross Margin %3.5%4.2%3.5%3.4%3.4%3.2%3.4%3.4%
Operating Income (EBIT)$1.3B$2.2B$1.6B$1.5B$1.0B$1.0B$1.3B$745M
Operating Margin %1.2%2.3%1.5%1.4%1.1%1.1%1.4%0.8%
Net Income$614M$1.7B$1.2B$1.1B$784M$1.3B$879M$241M
Net Margin %0.6%1.8%1.1%1.1%0.8%1.4%0.9%0.3%
EBITDA$1.4B$2.3B$1.8B$1.7B$1.3B$1.7B$1.4B$775M
Earnings Per Share (EPS)$5.15$13.71$9.59$8.92$6.25$10.01$6.94$1.86
Shares Outstanding (M)119M123M124M124M126M126M127M129M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Free Cash Flow History

Cash flowTTM → 2026-06-302026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Cash from Operations (CFO)$6.9B$6.2B$6.1B$4.3B$5.2B$4.4B$4.5B$4.4B$4.0B$4.3B$4.7B$3.7B$3.1B$3.1B$2.5B$3.0B$2.3B$2.3B$1.4B$869M$1.5B
Capital Expenditures (CapEx)$668M$745M$859M$687M$558M$535M$641M$506M$557M$580M$562M$677M$545M$415M$406M$403M$388M$378M$392M$356M$306M
Free Cash Flow (FCF)$6.2B$5.4B$5.2B$3.6B$4.6B$3.9B$3.9B$3.9B$3.5B$3.8B$4.2B$3.0B$2.6B$2.7B$2.1B$2.5B$1.9B$1.9B$959M$513M$1.2B
FCF Margin %1.5%1.3%1.5%1.2%1.7%1.5%1.6%1.7%1.6%1.8%2.1%1.6%1.4%2.0%1.7%2.1%1.7%1.8%0.9%0.5%1.3%
Dividends Paid$393M$381M$345M$314M$292M$277M$276M$294M$292M$262M$253M$244M$227M$214M$194M$195M$171M$131M$116M$70M$72M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)($220M)$3.4B$1.2B$2.4B($918M)$7.7B($2.4B)$2.1B
Capital Expenditures (CapEx)$112M$185M$175M$196M$189M$278M$196M$218M
Free Cash Flow (FCF)($332M)$3.2B$1.1B$2.2B($1.1B)$7.5B($2.6B)$1.9B
FCF Margin %-0.3%3.4%1.0%2.2%-1.1%8.2%-2.7%2.0%
Dividends Paid$102M$101M$101M$89M$90M$91M$92M$80M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MCK Balance Sheet History

Balance sheet2026-06-302026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
Total Assets$88.3B$82.3B$75.1B$67.4B$62.3B$63.3B$65.0B$61.2B$59.7B$60.4B$61.0B$56.6B$53.9B$51.8B$34.8B$33.1B$30.9B$28.2B$25.3B$24.6B$23.9B
Cash & Cash Equivalents$5.2B$4.0B$5.7B$4.6B$4.7B$3.5B$6.3B$4.0B$3.0B$2.7B$2.8B$4.0B$5.3B$4.2B$2.5B$3.1B$3.6B$3.7B$2.1B$1.4B$2.0B
Total Liabilities$92.2B$83.2B$76.8B$69.0B$63.8B$65.1B$63.6B$54.5B$50.0B$48.9B$48.4B$46.1B$44.4B$41.4B$27.7B$26.3B$23.7B$20.7B$19.1B$18.5B$17.7B
Total Debt (Short + Long-Term)$10.0B$6.8B$5.9B$5.9B$5.9B$6.2B$7.5B$7.7B$7.6B$4.7B$5.6B$4.3B$9.8B$10.4B$4.9B$4.0B$4.0B$2.3B$2.5B$1.8B$2.0B
Total Shareholders' Equity($4.2B)($2.2B)($1.7B)($1.6B)($1.5B)($1.8B)$1.4B$6.7B$9.7B$11.5B$12.6B$10.4B$9.5B$10.3B$7.1B$6.8B$7.2B$7.5B$6.2B$6.1B$6.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MCK viewer.

MCK Metric Deep Dives

Other Companies in Health Care Distributors

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← MCIAll “M” companiesMCL →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.